Feed RDY
RD
Dr. Reddy's Laboratories
RDY · NYSE
$11.67 -7.13% (-$0.90)
1M -9.42%
Market Cap ₹1.0T
P/E Ratio 17.79x
Div. Yield 0.73%
ROE 16.68%
Bulios Fair Price
$114.08
878.0% upside
Aktuální cena
$11.67
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
31 /100
Expensive P/FCF 30.25x
P/S 2.91x
P/B 2.81x
Growth
72 /100
Growing Rev. growth 14.94%
FCF growth 9.92%
Book val. growth 20.50%
Profitability
64 /100
Moderate Net margin 16.36%
Op. margin 19.20%
FCF margin 9.62%
Quality
52 /100
Average ROE 16.68%
ROA 10.46%
Asset turnover 0.64x
Debt
84 /100
Low Current ratio 1.85x
Int. coverage 22.07x
Net debt/EBITDA 0.52x
Stability
50 /100
Moderate Rev. volatility 1.55%
EPS volatility 46.77%
Profitable years 6
Zeptejte se StockBota na RDY
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Erez Israeli
Employees
27,527
Headquarters
Hyderabad